02355nam a2200421 a 4500 ebr10439396 CaPaEBR m u cr cn||||||||| 110112s2010 dcu sb 100 0 eng d 2010284668 0309157714 9780309157711 CaPaEBR CaPaEBR (OCoLC)672515579 QH437 .I57 2010eb Institute of Medicine (U.S.) The value of genetic and genomic technologies [electronic resource] : workshop summary / Theresa Wizemann and Adam C. Berger, rapporteurs ; Institute of Medicine of the National Academies. Washington, D.C. : National Academies Press, c2010. xv, 92 p. "Roundtable on Translating Genomic-Based Research for Health, Board on Health Sciences Policy." Includes bibliographical references. Tumor-based screening for Lynch Syndrome -- Pharmacogenomic testing to guide warfarin dosing -- Genomic profiling -- Closing remarks. "Knowing one's genetic disposition to a variety of diseases, including common chronic diseases, can benefit both the individual and society at large. The IOM's Roundtable on Translating Genomic-Based Research for Health held a workshop on March 22, 2010, to bring together diverse perspectives on the value of genetic testing, and to discuss its use in clinical practice"--home page. Electronic reproduction. Palo Alto, Calif. : ebrary, 2013. Available via World Wide Web. Access may be limited to ebrary affiliated libraries. Genomics Congresses. Genomics Research Congresses. Human chromosome abnormalities Diagnosis Congresses. Genetic counseling Congresses. Genetic disorders Diagnosis Congresses. Electronic books. local Wizemann, Theresa M. Berger, Adam C. Institute of Medicine (U.S.). Roundtable on Translating Genomic-Based Research for Health. Institute of Medicine (U.S.). Board on Health Sciences Policy. ebrary, Inc. http://site.ebrary.com/lib/rucke/Doc?id=10439396 An electronic book accessible through the World Wide Web; click to view 133807 133807